compounded glp 1 microdose GLP-1 Protocol Microdose
Description
Exercise timing Intense exercise within an hour of sublingual dosing may increase nausea
Pharmacological studies in rodents support an association between the use of GLP-1 RAs and the development of medullary thyroid cancer (MTC) resulting in a black box warning for these agents in patients at risk for this condition
2014;164A(3):6715
Human clinical trials for the specific GLP3 + cagrilintide combination are absent from peer-reviewed literature
Side effect-wise, it's the same
But relevant in a GLP-1 targeted supplement are the metabolic effects
